Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-03

Clinical Trial Update: Effects of Omalizumab Compared to Non-Omalizumab Treatment in Asthma Patients

View source ↗

Summary

Clinical trial update comparing omalizumab to non-omalizumab treatment in asthma patients. The status of the trial is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xolair (omalizumab)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Asthma | Status: UNKNOWN